Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Global MHC-Peptide Tetramer Market Insights, Forecast to 2031
... Tetramer is estimated to increase from 63.45 million USD in 2024 to reach 116.42 million USD by 2031, at a CAGR of 9.80% during the forecast period of 2025 through 2031. Europe market for MHC-Peptide ... Read More
-
The 2026-2031 World Outlook for Anti-Inflammatory Lupus Drugs
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Autoimmune Disorder Diagnostics
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Autoimmune Disease Diagnostics
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2026-2031 World Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics
... in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric ... Read More
-
The 2026-2031 World Outlook for Guillain-Barre Syndrome Therapeutics
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Autoimmune Disease Therapeutics
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
2025 Blood & AutoImmune Diseases Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the blood and blood-forming ... Read More
-
The 2026-2031 World Outlook for Autoimmune Treatments
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
... been predominantly fueled by heightened awareness and education regarding the safety, efficacy, and interchangeability of biosimilar products. Additionally, favorable insurance coverage and reimbursement structures implemented by both public and private payers have played a crucial ... Read More
-
Global Bio-pharma Market 2025-2029
... analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, ... Read More
-
Autoimmune Disease Diagnostics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034
... driven by the rising prevalence of chronic autoimmune conditions, increasing awareness of early diagnosis, and continuous technological innovations in diagnostic testing platforms. Autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis are affecting millions ... Read More
-
Intravenous Immunoglobulin (IVIg)
... at a CAGR of 8.5% over the analysis period 2024-2030. IgA, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$13.7 Billion by the end of the ... Read More
-
Autoimmune Disease Therapeutics
... at a CAGR of 3.8% over the analysis period 2024-2030. Anti-inflammatory, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$183.0 Billion by the end of the ... Read More
-
Lupus Therapeutics
... CAGR of 8.7% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Systemic Lupus Erythematosus (Sle) Drugs
... Million by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$68.0 Million While China is Forecast to Grow at 6.1% CAGR The Systemic Lupus Erythematosus ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Thyroid Gland Disorder Treatment
... 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Hypothyroidism, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.6 Billion by the end ... Read More
-
Immunotherapy Drugs
... CAGR of 9.6% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$254.4 Billion by the end of the analysis ... Read More
-
Global Thyroid Gland Disorders: Diagnostics and Treatment Market
... for the forecast period of 2026 through 2030. The market is segmented by type of disease, product type, end user and region. The disease types are segmented into hypothyroidism, hyperthyroidism, thyroid cancer, and others. Product ... Read More
-
2025 Global Forecast for Localized Autoimmune Disease Diagnostics Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Immunomodulator Therapeutics Market, Global, 2024–2030
... and regulate pathological immune responses, either by inhibiting or suppressing them. It categorizes the market by modality and key indications, providing a 6-year revenue forecast for global immunomodulator prescription drugs, alongside an analysis of key ... Read More
-
Dermatomyositis (DM): Market View
... 2024, which is expected to increase slightly to 848,500 diagnosed prevalent cases by 2029. Currently, the DM market is saturated with generic drugs, and the glucocorticoid receptor agonist drug class dominates the approved innovator drugs ... Read More
-
Animal Stem Cell Therapy Market By Product Type (Autologous Stem Cell Therapy and Allogeneic Stem Cell Therapy), By Type of Stem Cells (Mesenchymal Stem Cells, Hematopoietic Stem Cells, Neural Stem Cells, and Induced Pluripotent Stem Cells), By Application (Osteoarthritis, Skin regeneration, Neurodegenerative diseases, and Autoimmune diseases), Species (Dogs, Cats and Horses), and End-User (Veterinary Clinics, Research Laboratories and Universities and Academic Institutions ), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
... Cells), By Application (Osteoarthritis, Skin regeneration, Neurodegenerative diseases, and Autoimmune diseases), Species (Dogs, Cats and Horses), and End-User (Veterinary Clinics, Research Laboratories and Universities and Academic Institutions ), Global Market Size, Segmental analysis, Regional Overview, ... Read More
Research Assistance
